advertisement

---

Aref AA 5

Showing records 1 to 5 | Display all abstracts from Aref AA

92541 Experience with netarsudil 0.02% and latanoprostene bunod 0.024% as adjunctive therapy for glaucoma
Mehta AA
European Journal of Ophthalmology 2021; 0: 1120672121998913

---

92038 Recent developments in the use of optical coherence tomography for glaucoma
Vazquez LE; Bye A
Current Opinions in Ophthalmology 2021; 32: 98-104

---

92541 Experience with netarsudil 0.02% and latanoprostene bunod 0.024% as adjunctive therapy for glaucoma
Kanu LN; Sood-Mendiratta S
European Journal of Ophthalmology 2021; 0: 1120672121998913

---

92038 Recent developments in the use of optical coherence tomography for glaucoma
Aref AA
Current Opinions in Ophthalmology 2021; 32: 98-104

---

92541 Experience with netarsudil 0.02% and latanoprostene bunod 0.024% as adjunctive therapy for glaucoma
Quinones R; Hawkins A; Lehrer RA; Malhotra K; Papas R; Hillman D; Wilensky JT; Aref AA; Vajaranant TS; Edward DP
European Journal of Ophthalmology 2021; 0: 1120672121998913

---